Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene and Molecular Pathway Characterization of the Response to Ozone Treatment in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Radio-chemotherapy

NCT06816095 is registered in ClinicalTrials.gov with Bernardino Clavo, MD, PhD as lead sponsor.

NCT NCT06816095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06816095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene and Molecular Pathway Characterization of the Response to Ozone Treatment in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Radio-chemotherapy
Lead sponsor
Bernardino Clavo, MD, PhD
Phase
Observational
Overall status
Recruiting
Start date
February 10, 2025
Completion date
August 14, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pelvic pain syndrome (cpps), gynecological cancers, radiation-induced disorder, radiotherapy side effects, side effect of chemotherapy